Early Stage Status For Dimension Therapeutics Keeps Us Cautious On This IPO
October 23, 2015 at 12:59 PM EDT
Dimension Therapeutics expects to raise $82.5 million in its upcoming IPO. Based in Cambridge, Massachusetts, it is a biotechnology company with a gene therapy platform for developing treatments for rare diseases associated with the liver.
